Mesenteric venous thrombosis with bowel infarction and hyperhomocysteinemia due to homozygous methylenetetrahydrofolate reductase C677T genotype

Vascular and Endovascular Surgery

Volumn 42, Issue 5, 2008, Pages 477-481

  Hotoleanu, Cristina ^a,b   Andercou, Octavian ^a   Andercou, Aurel ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b NONE   (Romania)

Author keywords

Hyperhomocysteinemia; Mesenteric venous thrombosis; Methylenetetrahydrofolate reductase C677T polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTICOAGULANT AGENT; CEFTRIAXONE; LOW MOLECULAR WEIGHT HEPARIN; METRONIDAZOLE; VITAMIN B GROUP;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DNA POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; HYPERHOMOCYSTEINEMIA; INTESTINE INFARCTION; INTESTINE RESECTION; LAPAROTOMY; MALE; MESENTERIC VEIN THROMBOSIS; VITAMIN SUPPLEMENTATION;

ABDOMINAL PAIN; ADULT; ANTICOAGULANTS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; HOMOZYGOTE; HUMANS; HYPERHOMOCYSTEINEMIA; INFARCTION; JEJUNUM; MALE; MESENTERIC VASCULAR OCCLUSION; MESENTERIC VEINS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); TREATMENT OUTCOME; VENOUS THROMBOSIS; VITAMIN B COMPLEX;

EID: 54049156457     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/1538574408316141     Document Type: Article

References (15)

1. Kumar S., Sarr M., Kamath P. Mesenteric venous thrombosis. N Engl J Med. 2001 ; 345: 1683-1688.
2. Tessier DJ, Williams RA Mesenteric venous thrombosis. http://www.emedicine.com/med/topic2753.htm. Accessed February 27, 2008.
3. Lui GA, Poniachik TJ, Quera PR, Bermudez EC Mesenteric vein thrombosis: clinical manifestations, treatment and outcome. Rev Med Chil. 2005 ; 133: 17-22.
4. Querre I., Gris JC, Dauzat M. Homocysteine and venous thrombosis. Semin Vasc Med. 2005 ; 5: 183-189
5. Den Heijer M., Koster T., Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep vein thrombosis. N Engl J Med. 1996 ; 334: 759-762.
6. Langman L., Ray JG, Evrovski J., et al. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism. Arch Intern Med. 2000 ; 160: 961-964.
7. Den Heijer M., Lewington S., Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost. 2005 ; 3: 292-299.
8. Margaglione M., D'Andrea G., d'Addedd M., et al. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A 20210 mutation. J Thromb Haemost. 1998 ; 79: 907-911.
9. Ray J., Kearon C., Yi Q., Sherindan P., Lonn E. Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial. Arch Intern Med. 2007 ; 146: 761-767.
10. Den Heijer M., Willems HP, Blom HJ, et al. Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial. Blood. 2007 ; 109: 139-144.
11. Kumar S., Kamath PS Acute superior mesenteric venous thrombosis: one disease or two ? Am J Gastroenterol. 2003 ; 98: 1299-1304.
12. Cho YP, Jung SM, Han MS, et al. Role of diagnostic laparoscopy in managing acute mesenteric venous thrombosis. Surg Laparosc Endosc Percutan Tech. 2003 ; 13: 215-217.
13. Bradbury MS, Kavanagh PV, Bechtold RE, et al. Mesenteric venous thrombosis: diagnosis and noninvasive imaging. Radiographics. 2002 ; 22: 527-541.
14. Choudhary AM, Grayer D., Nelson A., Roberts I. Mesenteric venous thrombosis: a diagnosis not to be missed! J Clin Gastroenterol. 2000 ; 31: 179-182.
15. Grisham A., Lohr J., Guenther JM, Engel AM Deciphering mesenteric venous thrombosis: imaging and treatment. Vasc Endovascular Surg. 2005 ; 39: 473-479.